Details
Title
Low-dose PTCy plus low-dose ATG as GVHD prophylaxis after UD-PBSCT for hematologic malignancies: a prospective, multicenter, randomized controlled trial
Author
Zu, Yingling 1
; Gui, Ruirui 1 ; Li, Zhen 1 ; Wang, Juan 1 ; Zhang, Yanli 1 ; Yu, Fengkuan 1 ; Zhao, Huifang 1 ; Zhan, Xinrong 2 ; Wang, Zhongliang 2 ; Xing, Pengtao 2 ; Wang, Xianjing 3 ; Wang, Huili 3 ; Song, Yongping 4 ; Zhou, Jian 1
1 Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Department of Hematology, Zhengzhou, China (GRID:grid.414008.9) (ISNI:0000 0004 1799 4638)
2 Central Hospital of Xinxiang, Department of Hematology, Xinxiang, China (GRID:grid.440161.6)
3 The Third People’s Hospital of Zhengzhou, Department of Hematology, Zhengzhou, China (GRID:grid.417239.a)
4 the First Affiliated Hospital of Zhengzhou University, Department of Hematology, Zhengzhou, China (GRID:grid.412633.1) (ISNI:0000 0004 1799 0733)
; Gui, Ruirui 1 ; Li, Zhen 1 ; Wang, Juan 1 ; Zhang, Yanli 1 ; Yu, Fengkuan 1 ; Zhao, Huifang 1 ; Zhan, Xinrong 2 ; Wang, Zhongliang 2 ; Xing, Pengtao 2 ; Wang, Xianjing 3 ; Wang, Huili 3 ; Song, Yongping 4 ; Zhou, Jian 1
1 Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Department of Hematology, Zhengzhou, China (GRID:grid.414008.9) (ISNI:0000 0004 1799 4638)
2 Central Hospital of Xinxiang, Department of Hematology, Xinxiang, China (GRID:grid.440161.6)
3 The Third People’s Hospital of Zhengzhou, Department of Hematology, Zhengzhou, China (GRID:grid.417239.a)
4 the First Affiliated Hospital of Zhengzhou University, Department of Hematology, Zhengzhou, China (GRID:grid.412633.1) (ISNI:0000 0004 1799 0733)
Pages
10
Publication year
2023
Publication date
Dec 2023
e-ISSN
20445385
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2764016859
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.